EyePoint Pharmaceuticals
EYPT
EYPT
83 hedge funds and large institutions have $275M invested in EyePoint Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
23% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 22
7.18% more ownership
Funds ownership: 84.87% → 92.05% (+7.2%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
83
Holding in Top 10
2
Calls
$610K
Puts
$399K
Top Buyers
| 1 | +$25.9M | |
| 2 | +$2.71M | |
| 3 | +$2.58M | |
| 4 |
BlackRock
New York
|
+$2M |
| 5 |
Axa
Paris,
France
|
+$2M |
Top Sellers
| 1 | -$6.21M | |
| 2 | -$2.85M | |
| 3 | -$2.4M | |
| 4 |
Millennium Management
New York
|
-$2.37M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.46M |